CADL

NASDAQStock

Candel Therapeutics, Inc.

$4.71-0.28 (-5.52%)

52-Week Range

$4.39
$8.90

Key Stats

Market Cap

258.3M

P/E Ratio

Dividend Yield

Beta

-0.90

Volume

1.1M

Avg Volume

1.9M

Performance

1M

-12.32%

3M

-13.69%

6M

+2.68%

YTD

-8.46%

1Y

-43.60%

3Y

+209.32%

5Y

-28.86%

Price Chart

ETF Exposure

CADL is held by 42 ETFs

ETFFund NameWeight
SBIOALPS Medical Breakthroughs ETF0.18%
IWCiShares Micro-Cap ETF0.05%
SBIO.LInvesco NASDAQ Biotech UCITS ETF0.02%
IBBQInvesco Nasdaq Biotechnology ETF0.02%
IBBiShares Biotechnology ETF0.02%
BIBProShares - Ultra Nasdaq Biotechnology0.01%
VTWGVanguard Russell 2000 Growth ETF0.01%
IWOiShares Russell 2000 Growth ETF0.01%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.01%
R2SC.LState Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)0.01%
VTWOVanguard Russell 2000 ETF0.01%
SC0K.DEInvesco Russell 2000 UCITS ETF0.01%
IWMiShares Russell 2000 ETF0.01%
RESMColumbia Research Enhanced Small Cap ETF0.01%
RSSLGlobal X - Russell 2000 ETF0.01%
XRS2.DEXtrackers Russell 2000 UCITS ETF 1C0.01%
XRSU.LXtrackers Russell 2000 UCITS ETF 1C0.01%
XSU.TOiShares U.S. Small Cap Index ETF (CAD-Hedged)0.01%
UWMProShares - Ultra Russell20000.01%
URTYProShares - UltraPro Russell20000.00%
VXFVanguard Extended Market ETF0.00%
SMMDiShares Russell 2500 ETF0.00%
HDGProShares - Hedge Replication ETF0.00%
IWNiShares Russell 2000 Value ETF0.00%
VTWVVanguard Russell 2000 Value ETF0.00%
AVSCAvantis U.S. Small Cap Equity ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%

About CADL ETF Exposure

Candel Therapeutics, Inc. (CADL) is held by 42 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 258.3M, CADL is a widely held institutional stock. The stock currently trades at $4.71. Investors can gain exposure to CADL through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CADL, sorted by portfolio weight.